Robert E. Swillo

418 citations

15 papers · 356 indexed · h-index 9

Impact in

Cardiology and Cardiovascular Medicine top 10%
- Cardiac electrophysiology and arrhythmias
- Atrial Fibrillation Management and Outcomes
Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms

Papers in ⓘ

Cardiology and Cardiovascular Medicine 13
- Cardiac electrophysiology and arrhythmias 10
- Atrial Fibrillation Management and Outcomes 3
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Cardiac Arrhythmias and Treatments 2
Molecular Biology 5
- Connexins and lens biology 4

Co-authors: James K. Hennan (12 shared papers)David L. Crandall (6 shared papers)John A. Butera (7 shared papers)Stephen J. Gardell (3 shared papers)Joel Kantrowitz (5 shared papers)Eric I. Rossman (5 shared papers)Hal S. Feldman (3 shared papers)Ketil Haugan (4 shared papers)
Journals: Journal of Pharmacology and Experimental Therapeutics (4 papers)Journal of Thrombosis and Haemostasis (2 papers)Journal of Cardiovascular Pharmacology (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Journal of Medicinal Chemistry (1 paper)
Partner nations: Canada United States Germany

In The Last Decade

Robert E. Swillo

15 papers receiving 338 citations

Peers

Countries citing papers authored by Robert E. Swillo

Since Specialization

Citations

This map shows the geographic impact of Robert E. Swillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Swillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Swillo more than expected).

Fields of papers citing papers by Robert E. Swillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Swillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Swillo. The network helps show where Robert E. Swillo may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert E. Swillo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert E. Swillo Line = papers co-authored together Robert E. Swillo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Rotigaptide (ZP123) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs Journal of Pharmacology and Experimental Therapeutics ·James K. Hennan, Robert E. Swillo, Gwen A. Morgan, James C. Keith, Robert G. Schaub, Robert P. Smith, Hal S. Feldman, Ketil Haugan, Joel Kantrowitz, Phil J. Wang, Aqel W. Abu‐Qare, John A. Butera, Bjarne Due Larsen, David L. Crandall	2006	71
2	Effect of tiplaxtinin (PAI‐039), an orally bioavailable PAI‐1 antagonist, in a rat model of thrombosis Journal of Thrombosis and Haemostasis ·James K. Hennan, Gwen A. Morgan, Robert E. Swillo, Thomas M. Antrilli, Cheryl P. Mugford, G P Vlasuk, Stephen J. Gardell, David L. Crandall	2008	51
3	The Gap Junction Modifier, GAP-134 [(2S,4R)-1-(2-Aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic Acid], Improves Conduction and Reduces Atrial Fibrillation/Flutter in the Canine Sterile Pericarditis Model Journal of Pharmacology and Experimental Therapeutics ·Eric I. Rossman, Kun Liu, Gwen A. Morgan, Robert E. Swillo, Julie A. Krueger, Stephen J. Gardell, John A. Butera, Matthew Gruver, Joel Kantrowitz, Hal S. Feldman, Jørgen S. Petersen, Ketil Haugan, James K. Hennan	2009	48
4	Evaluation of PAI-039 [{1-Benzyl-5-[4-(trifluoromethoxy)phenyl]-1 H-indol-3-yl}(oxo)acetic Acid], a Novel Plasminogen Activator Inhibitor-1 Inhibitor, in a Canine Model of Coronary Artery Thrombosis Journal of Pharmacology and Experimental Therapeutics ·James K. Hennan, Hassan Elokdah, Mauricio Leal, Allena Ji, Gregory S. Friedrichs, Gwen A. Morgan, Robert E. Swillo, Thomas M. Antrilli, Amy L. Hreha, David L. Crandall	2005	35
5	Pharmacologic inhibition of platelet vWF-GPIbα interaction prevents coronary artery thrombosis Thrombosis and Haemostasis ·Robert E. Swillo, G. F. V. Morgan, Courtney E. Leik, Jonathan Brooks, Gray D. Shaw, Robert G. Schaub, David L. Crandall, George P. Vlasuk, James K. Hennan	2006	35
6	Discovery of (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid Hydrochloride (GAP-134)¹³, an Orally Active Small Molecule Gap-Junction Modifier for the Treatment of Atrial Fibrillation Journal of Medicinal Chemistry ·John A. Butera, Bjarne Due Larsen, James K. Hennan, Edward H. Kerns, Li Di, Asaf Alimardanov, Robert E. Swillo, Gwen A. Morgan, Kun Liu, Qiang Wang, Eric I. Rossman, Rayomand J. Unwalla, Leonard A. McDonald, Christine Huselton, Jørgen S. Petersen	2009	35
7	Sphingosine Modulates Myocyte Electrophysiology, Induces Negative Inotropy, and Decreases Survival After Myocardial Ischemia Journal of Cardiovascular Pharmacology ·Gregory S. Friedrichs, Robert E. Swillo, Brian Jow, Terry Bridal, Randy Numann, Linda M. Warner, Loran M. Killar, Kurex Sidek	2002	29
8	GAP-134 ([2S,4R]-1-[2-Aminoacetyl]4-Benzamidopyrrolidine-2-Carboxylic Acid) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs Journal of Cardiovascular Pharmacology and Therapeutics ·James K. Hennan, Robert E. Swillo, Gwen A. Morgan, Eric I. Rossman, Joel Kantrowitz, John A. Butera, Jørgen S. Petersen, Stephen J. Gardell, George P. Vlasuk	2009	20
9	WAY-140312 reduces plasma PAI-1 while maintaining normal platelet aggregation Biochemical and Biophysical Research Communications ·David L. Crandall, James K. Hennan, Hassan Elokdah, Girija Krishnamurthy, Thomas M. Antrilli, Jean S. Bauer, Gwen A. Morgan, Robert E. Swillo	2003	10
10	Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents Bioorganic & Medicinal Chemistry Letters ·Eugene L. Piatnitski Chekler, John A. Butera, Li Di, Robert E. Swillo, Gwen A. Morgan, Eric I. Rossman, Christine Huselton, Bjarne Due Larsen, James K. Hennan	2009	8
11	Effect of Timing of Treatment of the Glyburide-Reversible Cardioprotective Activity of BMS-180448 Journal of Pharmacology and Experimental Therapeutics ·Allen W. Gomoll, R A Roth, Robert E. Swillo, Anne J. Baird, C S Sargent, Ronald W. Behling, Harold Malone, Gary J. Grover	1997	7
12	ZP123 Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs James K. Hennan, Hal S. Feldman, Robert E. Swillo, Gwen A. Morgan, James C. Keith, Robert G. Schaub, Robert P. Smith, Ketil Haugan, Joel Kantrowitz, John A. Butera, David L. Crandall	2005	4
13	ID: 190 Efficacy of PAI-749, an orally active PAI-1 inhibitor, in dog and rat models of arterial and venous thrombosis Journal of Thrombosis and Haemostasis ·James K. Hennan, Gwen A. Morgan, Robert E. Swillo, Allen Ji, Longfei Guan, D. Crandall	2006	1
14	The pharmacodynamics of bucainide (RHC G233): pharmacokinetic parameters and relationship between plasma levels and the effect on the electrocardiogram in the dog. PubMed ·Peter E. Grebow, William P. Feeney, M Johnston, John Lettieri, H Li, E Magnien, Paul O’Brien, Robert E. Swillo, Ira Weinryb, Peter Wolf, Juan Carlos Marsiglia	1981	1
15	Abstract 1837: Effects of the Gap Junction Modifier, GAP-134, on Conduction and Atrial Fibrillation/Flutter Inducibility in Dogs Circulation ·Eric I. Rossman, Kun Liu, Gwen A. Morgan, Robert E. Swillo, John A. Butera, Matthew Gruver, Joel Kantrowitz, Ketil Haugan, Jørgen S. Petersen, James K. Hennan	2007	1

About Robert E. Swillo

Robert E. Swillo is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Hematology, Cancer Research and Surgery, having authored 15 papers that have together received 356 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (10 papers), Connexins and lens biology (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Atrial Fibrillation Management and Outcomes (3 papers), Protease and Inhibitor Mechanisms (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Cardiac Arrhythmias and Treatments (2 papers) and Cardiac Ischemia and Reperfusion (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (153 citations), Hematology (75 citations), Internal Medicine (25 citations), Cancer Research (54 citations) and Emergency Medicine (30 citations). Robert E. Swillo has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include James K. Hennan, David L. Crandall, John A. Butera, Stephen J. Gardell, Joel Kantrowitz, Eric I. Rossman, Hal S. Feldman, Ketil Haugan, Robert G. Schaub and Jørgen S. Petersen. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Thrombosis and Haemostasis, Journal of Cardiovascular Pharmacology, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact